Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03955471 |
| Title | Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer (MOONSTONE) |
| Acronym | MOONSTONE |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Scottsdale | Arizona | 85258 | United States | Details | |
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | Newport Beach | California | 92663 | United States | Details | |
| GSK Investigational Site | Orange | California | 92868 | United States | Details | |
| GSK Investigational Site | Solvang | California | 93463 | United States | Details | |
| GSK Investigational Site | Deerfield Beach | Florida | 33442 | United States | Details | |
| GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
| GSK Investigational Site | Orlando | Florida | 32804 | United States | Details | |
| GSK Investigational Site | Tampa | Florida | 33612 | United States | Details | |
| GSK Investigational Site | Iowa City | Iowa | 52242-1009 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | Burlington | Massachusetts | 01805 | United States | Details | |
| GSK Investigational Site | Minneapolis | Minnesota | 55404 | United States | Details | |
| GSK Investigational Site | Jackson | Mississippi | 39216 | United States | Details | |
| GSK Investigational Site | New York | New York | 10022 | United States | Details | |
| GSK Investigational Site | Durham | North Carolina | 27710 | United States | Details | |
| GSK Investigational Site | Cleveland | Ohio | 44106 | United States | Details | |
| GSK Investigational Site | Cleveland | Ohio | 44124 | United States | Details | |
| GSK Investigational Site | Eugene | Oregon | 97401 | United States | Details | |
| GSK Investigational Site | Providence | Rhode Island | 02905 | United States | Details | |
| GSK Investigational Site | Chattanooga | Tennessee | 37403 | United States | Details | |
| GSK Investigational Site | Germantown | Tennessee | 38138 | United States | Details | |
| GSK Investigational Site | Austin | Texas | 78731 | United States | Details | |
| GSK Investigational Site | Fort Worth | Texas | 76104 | United States | Details | |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
| GSK Investigational Site | Charlottesville | Virginia | 22903 | United States | Details |